Literature DB >> 11239946

Antibody types and IgG subclasses in paraneoplastic neurological syndromes.

J E Greenlee1, J W Boyden, M Pingree, H R Brashear, S A Clawson, P M Keeney.   

Abstract

Three major patterns of antineuronal antibody response have been identified in patients with paraneoplastic neurological syndromes: Type I ('Anti-Yo'), associated with cerebellar degeneration in the setting of breast or gynecological cancer, Type IIa ('anti-Hu') associated with encephalomyeloneuritis in patients with small cell carcinoma of the lung, and Type IIb ('anti-Ri') associated with breast cancer. We have employed immunofluorescence methods to determine the antibody classes and the IgG subclasses which react with neurons in each of these patterns of paraneoplastic antibody response. In this study, IgG was the only antibody class identified; IgM and IgA antibodies were not found. IgG1 was the major subclass represented and was found in 9/9 patients with Type I antibody response, 26/27 patients with Type IIa antibody response, and 3/3 patients with Type IIb antibody response. Many patients also exhibited positive staining for IgG2 and IgG3. Trace amounts of IgG4 antineuronal antibodies were detected in a single patient with Type I antibody response; IgG4 antibodies were not found in other patients. Patients with paraneoplastic neurological syndromes exhibit an antibody response which is overwhelmingly IgG and is comprised predominantly of IgG subclasses capable of fixing complement. The role of these antibodies in the pathogenesis of paraneoplastic neurological disease remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239946     DOI: 10.1016/s0022-510x(01)00442-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Molecular evolution of IgG subclass among nonhuman primates: implication of differences in antigenic determinants among Apes.

Authors:  Yoko Asada; Yoshi Kawamoto; Takayoshi Shotake; Keiji Terao
Journal:  Primates       Date:  2002-10       Impact factor: 2.163

2.  Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.

Authors:  Kenneth E Hill; Susan A Clawson; John W Rose; Noel G Carlson; John E Greenlee
Journal:  J Neuroinflammation       Date:  2009-10-29       Impact factor: 8.322

3.  Paraneoplastic neurological syndrome as an initial indicator of small cell carcinoma of the lung.

Authors:  Lénea Porto; Mafalda Miranda; Ana Gomes; Rui André; Bárbara Rodrigues
Journal:  BMJ Case Rep       Date:  2013-02-06

Review 4.  Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.

Authors:  A P Meert; M Paesmans; T Berghmans; B Martin; C Mascaux; F Vallot; J M Verdebout; J J Lafitte; J P Sculier
Journal:  BMC Cancer       Date:  2001-06-19       Impact factor: 4.430

Review 5.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 6.  Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: A beneficial antitumor immune response going awry.

Authors:  Béatrice Sl Pignolet; Christina Mt Gebauer; Roland S Liblau
Journal:  Oncoimmunology       Date:  2013-12-10       Impact factor: 8.110

7.  Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features.

Authors:  Elise Peter; Le Duy Do; Salem Hannoun; Sergio Muñiz-Castrillo; Alberto Vogrig; Valentin Wucher; Anne-Laurie Pinto; Naura Chounlamountri; Walaa Zakaria; Veronique Rogemond; Geraldine Picard; Julien-Jacques Hedou; Aditya Ambati; Agusti Alentorn; Alexandra Traverse-Glehen; Mario Manto; Dimitri Psimaras; Emmanuel Mignot; Francois Cotton; Virginie Desestret; Jérôme Honnorat; Bastien Joubert
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-08-08

Review 8.  Paraneoplastic Diseases of the Central Nervous System.

Authors:  Jonathan Galli; John Greenlee
Journal:  F1000Res       Date:  2020-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.